NIVF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
NewGenIvf Group Ltd (NIVF) is not a strong buy for a beginner, long-term investor at this time. While the company shows some revenue growth, the significant negative net income, declining EPS, and gross margin, combined with no strong trading signals or positive catalysts, make it a less attractive investment currently. The technical indicators also do not suggest a clear entry point, and the stock's short-term trend indicates potential downside.
The MACD is positive and expanding, indicating a bullish trend. However, the RSI is in the neutral zone at 74.629, and moving averages are converging, which does not provide a clear signal. The stock is trading near its resistance level (R1: 2.417), which could limit further upside in the short term.
Revenue increased by 11.85% YoY in the latest quarter, indicating some growth in the business.
Net income remains significantly negative (-7668922), EPS has dropped drastically (-97.41% YoY), and gross margin has declined (-13.09% YoY). No recent news or trading trends from insiders or hedge funds to support a bullish sentiment. Short-term stock trend analysis predicts a potential decline in the next week and month.
In Q4 2025, revenue increased by 11.85% YoY, but net income remains deeply negative (-7668922), albeit improving significantly. EPS dropped by 97.41% YoY to -7.39, and gross margin declined to 36.79% (-13.09% YoY).
No analyst rating or price target changes available.
